Dividendos de 22nd Century Group

Dividendo controles de criterios 0/6

22nd Century Group no tiene historial de pago de dividendo.

Información clave

n/a

Rentabilidad por dividendo

n/a

Ratio de pago

Rentabilidad media de la industria	6.0%
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Beneficios por acción	-US$10.70
Rentabilidad por dividendo prevista a 3 años	n/a

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher

Apr 02

Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook

Aug 20

With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For

Jun 14

Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?

Jan 13

22nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado

Oct 03

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de XXII han sido estables en el pasado.

Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de XXII han aumentado.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de 22nd Century Group vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de XXII con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (XXII)	n/a
Suelo de mercado 25% (US)	1.5%
Techo de mercado 25% (US)	4.7%
Media de la industria (Tobacco)	6.0%
Previsión de analistas en 3 años (XXII)	n/a

Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de XXII en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Alto dividendo: No es posible evaluar la rentabilidad por dividendo de XXII en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Pago de beneficios a los accionistas

Cobertura de los beneficios: No hay datos suficientes para calcular el ratio de pago de XXII para determinar si sus pagos de dividendos están cubiertos por los beneficios.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que XXII no ha comunicado ningún pago.

Discover strong dividend paying companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Dividendos de 22nd Century Group

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos

Recent updates

22nd Century Group, Inc. announced that it has received $4.2 million in funding

22nd Century Group, Inc. has filed a Follow-on Equity Offering in the amount of $4.237199 million.

22nd Century Group Receives Deficiency Letter from Nasdaq Regarding Non-Compliance with Nasdaq's Listing Rule 5550(b)(1)

Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher

New major risk - Share price stability

No longer forecast to breakeven

Full year 2023 earnings released: US$3.12 loss per share (vs US$4.65 loss in FY 2022)

22nd Century Group, Inc. to Report Q4, 2023 Results on Mar 28, 2024

22Nd Century Group, Inc. Announces Termination of Peter Ferola as the Chief Legal Officer and Corporate Secretary

High number of new directors

22Nd Century Group, Inc. Appoints Lawrence (Larry) Firestone as Chief Executive Officer

Specialty Acquisition Corporation entered into a equity purchase agreement to acquire Substantially all of GVB hemp/cannabis business from 22nd Century Group, Inc. (NasdaqCM:XXII) and ESI Holdings, LLC for $2.3 million.

Consensus EPS estimates fall by 67%

New major risk - Market cap size

22nd Century Group Receives Non-Compliance Letter from Nasdaq

22nd Century Group, Inc. Continues VLN Expansion, Now Retailing in More Than 5,100 Stores

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

New major risk - Shareholder dilution

22Nd Century Group, Inc. Adds 1,200 Drug Store Locations Selling VLN in Five States

Consensus revenue estimates fall by 11%

Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook

Price target decreased by 27% to US$31.19

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

22nd Century Group, Inc. to Report Q2, 2023 Results on Aug 14, 2023

Pomerantz LLP Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of 22nd Century Group, Inc. Common Stock

High number of new directors

22Nd Century Group, Inc. Announces Chief Executive Officer Changes

22nd Century Group Regains Compliance with Nasdaq Listing Standards

22Nd Century Group, Inc. Announces Its Vln(R) Reduced Nicotine Content C-Stores

New minor risk - Share price stability

22nd Century Announces 1-For-15 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

New minor risk - Market cap size

22nd Century Group, Inc. Announces Production of VLN(R) Homogenized Tobacco Leaf Sheet

22nd Century Group, Inc. Announces VLN(R) Products Launch in Nevada to Help Smokers Smoke Less

With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For

22Nd Century Group, Inc. Launches Vln At #1 U.S. C-Store Chain in Texas, California and Florida

Consensus revenue estimates increase by 10%, EPS downgraded

22nd Century Group, Inc. Provides Revenue Guidance for the Full Year 2023

Price target decreased by 11% to US$4.00

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

22nd Century Group, Inc. to Report Q1, 2023 Results on May 09, 2023

Consensus EPS estimates fall by 16%

Full year 2022 earnings: EPS and revenues miss analyst expectations

22nd Century Group, Inc. (NasdaqCM:XXII) acquired Rx Pharmatech Ltd for $0.65 million.

Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?

Forecast to breakeven in 2025

Key Executive notifies of intention to sell stock

22Nd Century Group, Inc. Appoints John J. Miller as an Executive Officer and President of Tobacco

High number of new directors

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

High number of new directors

22nd Century Group, Inc. to Report Q3, 2022 Results on Nov 08, 2022

22nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado

High number of new directors

22Nd Century Group Appoints Lucille S. Salhany to Its Board

22Nd Century Group, Inc. Announces Executive Changes

22nd Century Group to expand sales of VLN tobacco cigarettes

22nd Century Group (NASDAQ:XXII) Has Debt But No Earnings; Should You Worry?

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

22nd Century GAAP EPS of -$0.06 in-line, revenue of $14.5M beats by $3.21M

Consensus forecasts updated

22nd Century Group, Inc. announced that it has received $35.000009 million in funding

22nd Century Group, Inc. to Report Q2, 2022 Results on Aug 09, 2022

22nd Century Group launches $35M securities offering

22Nd Century Group, Inc. Announces the Appointment of R. Hugh Kinsman as Its Chief Financial Officer

22nd Century Group, Inc. announced that it has received funding

22nd Century Group Announces John J. Miller Joins Its Tobacco Business

Key Executive exercised options to buy US$179k worth of stock.

22nd Century Group, Inc. (NasdaqCM:XXII) acquired GVB BioPharma for $51.7 million.

Will 22nd Century Group (NASDAQ:XXII) Spend Its Cash Wisely?

22nd Century Group: Record Revenues On VLN Cigarettes And Cannabis IP

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to US$5.50

High number of new directors

22nd Century Group, Inc., Annual General Meeting, Jun 16, 2022